The U.S. topical pain relief market was valued at $2,612 million in 2019, and is projected to reach $3,272 million by 2027 at a CAGR of 3.7% from 2020 to 2027.
Pain is a distressing feeling caused by intense or damaging stimuli and it is one of the most common reasons for physician consultation in the U.S. Analgesics or painkillers are used to reduce and treat body pain. Whenever these analgesics are applied directly to the skin they are known as topical pain relief medications. These include topical administration of drugs such as non-steroidal anti-inflammatory drugs, anesthetics, capsaicin, and opioids. Topical pain relief medications exert peripheral effects near the site of application and minimize the pain.
Increase in prevalence of arthritis and joint pain is the major factor that contributes toward the growth of the topical pain relief market in the U.S. Moreover, other factors that fuel the market growth include growth in geriatric population, lesser side effects caused due to use of topical analgesics as compared to oral pain relief, wide availability of topical pain relieving drugs, and high demand for topical pain relief by sports players. However, topical pain relief medications can cause irritated skin and they have a strong odor or unpleasant smell that impede the market growth. Conversely, development of online platform for the topical therapeutics is expected to provide lucrative opportunities for the market growth.
The U.S. topical pain relief market is segmented into therapeutic class, type, formulation, and distribution channel. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioids segment is further divided into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, capsaicin, lidocaine, and other non-opioids. The opioids segment is further bifurcated into buprenorphine and fentanyl. On the basis of type, the market is segmented into prescription pain relief and over-the-counter (OTC) relief. On the basis of formulation, the market is classified into cream, gel, spray, patch, and others. The distribution channels covered in the study include pharmacies & drug stores, e-commerce, and retail & grocery stores
Increase in prevalence of arthritis and joint pain is the major factor that contributes toward the growth of the topical pain relief market in the U.S. Moreover, other factors that fuel the market growth include growth in geriatric population, lesser side effects caused due to use of topical analgesics as compared to oral pain relief, wide availability of topical pain relieving drugs, and high demand for topical pain relief by sports players. However, topical pain relief medications can cause irritated skin and they have a strong odor or unpleasant smell that impede the market growth. Conversely, development of online platform for the topical therapeutics is expected to provide lucrative opportunities for the market growth.
The U.S. topical pain relief market is segmented into therapeutic class, type, formulation, and distribution channel. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioids segment is further divided into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, capsaicin, lidocaine, and other non-opioids. The opioids segment is further bifurcated into buprenorphine and fentanyl. On the basis of type, the market is segmented into prescription pain relief and over-the-counter (OTC) relief. On the basis of formulation, the market is classified into cream, gel, spray, patch, and others. The distribution channels covered in the study include pharmacies & drug stores, e-commerce, and retail & grocery stores
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
- The profiles and growth strategies of the
KEY PLAYERS
are thoroughly analyzed to understand the competitive outlook of the market.
Key Market Segments
By Therapeutic Class
- Non-opioids
- Nonsteroidal anti-inflammatory drug (NSAIDS)
- Methyl Salicylate
- Capsaicin
- Lidocaine
- Other Non-opioids
- Opioids
- Buprenorphine
- Fentanyl
By Formulation
- Cream
- Gel
- Spray
- Patch
- Others
By Type
- Prescription Pain Relief
- Over-the-counter (OTC) Pain Relief
By Distribution Channel
- Pharmacy & Drug Store
- e-Commerce
- Retail & Grocery Store
List of Key Players profiled in the report
- AdvaCare Pharma
- GlaxoSmithKline plc (GSK)
- Johnson & Johnson
- Nestlé S.A.
- Novartis AG
- Pfizer Inc.
- Reckitt Benckiser Group plc
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Topical BioMedics, Inc.
List of OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- Cipla Limited
- Glenmark Pharmaceuticals Limited
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: U.S. TOPicAL PAIN RELIEF MARKET, BY THERAPEUTic CLASS
CHAPTER 5: U.S. TOPicAL PAIN RELIEF MARKET, BY FORMULATION
CHAPTER 6: U.S. TOPicAL PAIN RELIEF MARKET, BY TYPE
CHAPTER 7: U.S. TOPicAL PAIN RELIEF MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 128 |
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 2612 million |
| Forecasted Market Value ( USD | $ 3272 million |
| Compound Annual Growth Rate | 2.9% |
| Regions Covered | United States |
